FDA delays Moderna for adolescents to review rare side effect
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -1.69% COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of a rare inflammatory heart condition, according to people familiar with the matter.
via DigioNews
Note : I Hope My My New News Article : FDA delays Moderna for adolescents to review rare side effect Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : FDA delays Moderna for adolescents to review rare side effect
0 تعليقات